Green Cross Corporation

CompanySouth Korea

Green Cross Corporation develops one asset, in phase 2 (Varicella Vaccine). Mostly vaccine; based in South Korea.

1
Asset
Furthest stage
Phase 2
3
Trials
3
Signals

Pipeline

1
  • Varicella Vaccine

    Induces protective immunity against varicella-zoster virus.

    Phase 2, Vaccine

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials4
  • Signals19
  • Integrity notices1

Intelligence